http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2658582-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2202-22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N31-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-18
filingDate 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e6d52989cb7bddd3ce989ce0c79f1a1
publicationDate 2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2658582-B1
titleOfInvention Glycols as pathogen inactivating agents
priorityDate 2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2350271-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0804074-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405879

Total number of triples: 26.